Brief: SeQuent Scientific says US FDA suspended manufacturing license at Mahad unit for 15 days
June 16 (Reuters) - SeQuent Scientific Ltd SEQU.NS : * US FDA passed order to suspend manufacturing license at Mahad unit for 15 days from July 1 * Unit continues to operate and co expects no business interruptions * Co has filed an appeal for staying and subsequent revocation of order * Source text: http://bit.ly/21nREjm * Further company coverage SEQU.NS ((Bengaluru Newsroom; +91 80 6749 1130))
Recent news on Viyash Scientific
See all newsBrief: Viyash Scientific Says Bioforlife Italia Acquisition Expected To Complete Within Two Months From Sept 8
Brief: Viyash Scientific Ltd June-Quarter Consol Net Profit 658.7 Million Rupees
Brief: Viyash Scientific's Subsidiary To Buy 100% Of Bioforlife Italia
Brief: Viyash Scientific March-Quarter Consol Net Profit 521.1 Million Rupees
Brief: Viyash Scientific Partners With Boehringer Ingelheim In India